GlycoMimetics (GLYC) Q1 2019 Earnings Call Transcript [The Motley Fool]
GlycoMimetics, Inc. (GLYC)
Last glycomimetics, inc. earnings: 5/1 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.glycomimetics.com/investor-relations
Company Research
Source: The Motley Fool
GlycoMimetics (GLYC) Q1 2019 Earnings Call Transcript Image source: The Motley Fool. GlycoMimetics ( NASDAQ:GLYC May. 0, 09 8:0 a.m. ET Contents: : Operator Good morning, and thank you all for joining GlycoMimetics first-quarter 09 conference call. [Operator instructions] I would now like to turn the call over to Sheri Annes of investor relations group at GlycoMimetics. Please go ahead. Investor Relations Good morning. Today, we will highlight the key achievements of 09's first quarter and update you on our key clinical development program. The press release we issued this morning on our Q financials is available on the news section of the company's website at www.glycomimetics.com. This call is being recorded. A dial-in phone replay will be available for hours after the close of the call. The webcast replay will also be available on the investor relations section of the company's website for 0 days. Joining me on the call today from GlycoMimetics are Rachel King, chief executive
Show less
Read more
Impact Snapshot
Event Time:
GLYC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GLYC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GLYC alerts
High impacting GlycoMimetics, Inc. news events
Weekly update
A roundup of the hottest topics
GLYC
News
- GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024PR Newswire
- GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual MeetingBusiness Wire
- GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYCGlobeNewswire
GLYC
Earnings
- 8/8/24 - Beat
GLYC
Sec Filings
- 11/13/24 - Form 10-Q
- 11/12/24 - Form SC
- 11/7/24 - Form DEFA14A
- GLYC's page on the SEC website